Reduction in clinically important deterioration in chronic obstructive pulmonary disease with aclidinium/formoterol

Abstract Background ‘Clinically important deterioration’ (CID) is a composite endpoint measuring worsening of the key clinical features of chronic obstructive pulmonary disease (COPD), namely lung function, patient-reported outcomes, and exacerbations. ACLIFORM and AUGMENT were two 24-week, randomiz...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Dave Singh, Anthony D. D’Urzo, Ferran Chuecos, Anna Muñoz, Esther Garcia Gil
Médium: Artigo
Jazyk:Inglês
Vydáno: BMC 2017-05-01
Edice:Respiratory Research
Témata:
COPD
LABA
LAMA
Bronchodilation
Chronic respiratory disease
On-line přístup:http://link.springer.com/article/10.1186/s12931-017-0583-0
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky